Challenges in Anti-addiction Drug Development: Lost in Translation?
Neuropharmacology and Therapy · 2026 · 3
DOI: 10.15212/npt-2026-0011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuropharmacology and Therapy, 2026. Verfasst von Jun-Xu Li. Die Arbeit nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sucht und Abhängigkeit
Abstract (Originalsprache)
Substance use disorder (SUD) affects millions of people worldwide and poses a critical global healthcare challenge. Despite decades of intensive research, few effective pharmacotherapies are currently available, and their clinical efficacy remains limited. Furthermore, these existing therapies are broadly underused, because of regulatory, social, and financial constraints. Industrial drug development for SUD has been comparatively stagnant, hampered by a lack of investment and commercial interest. Historically, drug discovery efforts in this field have faced exceptionally high failure rates. This article discusses the factors contributing to these barriers, emphasizing that these clinical failures are directly driven by a lack of animal models with well-established predictive validity. Additionally, the extensive gap between laboratory animals and human participants in clinical trials poses a major hurdle to successful translation. This trend might potentially be reversed through more sophisticated nonclinical strategies, such as the use of genetically diverse animals and patient-aligned animal stratification, to better bridge the gap between fundamental neurobiological discoveries and effective clinical interventions.
Zitieren
APA
Li, J. (2026). Challenges in Anti-addiction Drug Development: Lost in Translation?. Neuropharmacology and Therapy, 3. https://doi.org/10.15212/npt-2026-0011
Vancouver
Li J. Challenges in Anti-addiction Drug Development: Lost in Translation?. Neuropharmacology and Therapy. 2026;3. doi:10.15212/npt-2026-0011
BibTeX
@article{Li2026,
author = {Li, Jun-Xu},
title = {Challenges in Anti-addiction Drug Development: Lost in Translation?},
journal = {Neuropharmacology and Therapy},
year = {2026},
volume = {3},
doi = {10.15212/npt-2026-0011}
}
EUVIMED